US › Healthcare

Beyond Air Inc (XAIR)

US · Healthcare · Medical Devices

$6.18-2.37%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

$1.9M

Revenue YoY

+65.5%

Net profit

$-10.3M

Profit YoY

-28.0%

EPS

$-0.77

EPS estimate

$-0.45

Net margin

-539.2%

EPS came in at -0.77 against a street estimate of -0.45 — a miss of 71.1%.

Key statistics

Market cap

$4.6M

Forward P/E

0.0

P/B

0.62

Book value

$10.39

EPS (TTM)

$-80.20

52-week high

$95.60

52-week low

$5.02

50-day MA

$7.68

200-day MA

$18.47

Beta

0.15

Analyst view

Analysts rate Beyond Air Inc a buy (4 buy, 1 hold, 0 sell out of 5) with an average price target of $160.00.

Shareholding

Insiders

8.05%

Institutions

8.11%

Largest institutional holders

Fund	Stake
Balyasny Asset Management LLC	3.22%
Murchinson Ltd.	2.29%
Geode Capital Management, LLC	1.11%
Daytona Street Capital LLC	1.09%
Bleichroeder LP	0.60%
Vanguard Capital Management, LLC	0.22%
Vanguard Fiduciary Trust Co	0.20%
WEALTH EFFECTS LLC	0.20%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Beyond Air Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.